Tenomix logo — Advancing innovative solutions to enhance pathology workflow...

Tenomix

Advancing innovative solutions to enhance pathology workflow, improve cancer treatment, and lower healthcare expenses.

Founded 2021 2-10 employees Grant Total: $2.64M Biotechnology, Health Care +1

General Information

Company Name Tenomix
Founded Year 2021
Employees 2-10
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Tenomix. To contact Tenomix, visit tenomix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Tenomix

Tenomix is a biotechnology startup founded in 2021 with a mission to develop innovative technologies that target inefficiencies in the pathology workflow, optimize cancer care, and reduce healthcare costs. The company's slogan, "Advancing innovative solutions to enhance pathology workflow, improve cancer treatment, and lower healthcare expenses," encapsulates its focus. In July 2024, the startup received a significant $500.00K grant investment from the Ministry of Economic Development, Job Creation and Trade. Tenomix operates in the industries of Biotechnology, Health Care, and Medical Devices. The company's efforts align with the current trends and needs in the healthcare sector, making it an attractive investment opportunity. With its innovative solutions and strategic focus, Tenomix presents promising potential for both impact and returns in the healthcare and biotech investment landscape.

Taxonomy: Pathology workflow, Cancer treatment, Healthcare expenses, Innovative solutions, Medical diagnostics, Cost reduction, Workflow optimization, Healthcare innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $500.00K 1
Ministry of Economic Development, Job Creation and Trade
08 Jul 2024
Seed Round $2.14M 4
Ontario Centres of Excellence, FACIT +2
01 Mar 2024
Grant Undisclosed 2
Startupfest, Business Development Bank of Canada
22 Aug 2023
Grant Undisclosed 2
Archangel Network of Funds, TechAlliance of Southwestern Ontario
04 Aug 2022

Tenomix Alternatives & Competitors

View All Alternatives
Tenomix vs

Pioneering innovative therapeutic solutions with specialized antibodies for cancer, viral, and autoi...

Venture round
51-200 employees
Biotechnology, Health Care
Tenomix vs
Deep Bio Inc.
Deep Bio Inc. Korea South

Al healthcare company with in-house expertise in deep learning and cancer pathology.

Series B
30 employees
AI, Biotechnology
Tenomix vs

Connecting People. Elevating Patient Care. Complete Pathology Workflows with Integrated Digital Path...

43 employees
AI, Biotechnology

FAQ About Tenomix

Advancing innovative solutions to enhance pathology workflow, improve cancer treatment, and lower healthcare expenses.
Tenomix was founded in 2021.
Tenomix operates in Biotechnology, Health Care and Medical Devices. Its work centres on Pathology workflow, Cancer treatment, Healthcare expenses and Innovative solutions.
Tenomix has approximately 2-10 employees.
Tenomix has completed 4 funding rounds, raising a total of $2.64M. The latest funding stage is Grant.
Top alternatives and competitors to Tenomix include Applied Immune Technologies, Deep Bio Inc., Virasoft Corporation, Sakura Finetek USA, BioPheresis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tenomix and Applied Immune Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tenomix, https://bouncewatch.com/company/tenomix, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes